43279-9

LOINC 2.82

Hepatitis B Virus YMDD [Presence] in Serum or Plasma by NAA with probe detection

HBV YMDD Mut SerPl Ql NAA+probe

Component

  • Hepatitis B virus YMDD mutation

Specimen / system

  • Ser/Plas

Class

  • ABXBACT

Property

  • PrThr

Scale

  • Ord

Method

  • Probe.amp.tar

Related names

  • 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; DNA NUCLEIC ACID PROBE; DNA probe; HBV; HBV YMDD Mut; Hep; Hep B; Hepatis; Hepatit; Hepatology; HepB; ID; Infectious Disease; InfectiousDisease; Lamivudine resistance; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Mut; Mutations; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification

Index terms

  • 3 Self-Sustaining Sequence Replication
  • 3SR SR
  • Amplif
  • Amplification
  • Amplified
  • ANTIBIOTIC SUSCEPTIBILITIES
  • DNA NUCLEIC ACID PROBE
  • DNA probe
  • HBV
  • HBV YMDD Mut
  • Hep
  • Hep B
  • Hepatis
  • Hepatit
  • Hepatitis B virus YMDD mutation
  • Hepatology
  • HepB
  • ID
  • Infectious Disease
  • InfectiousDisease
  • Lamivudine resistance
  • LAT
  • LCR
  • Ligase chain reaction
  • Ligation-activated transcription
  • Liver
  • Mut
  • Mutations
  • NAA+probe
  • NAAT
  • NASBA
  • Nucleic acid sequence based analysis
  • Ordinal
  • PCR
  • Pl
  • Plasma
  • Plsm
  • Point in time
  • Polymerase chain reaction
  • PR

19 further terms